Furthermore, the high expression of HOTTIP is correlated with lymph node metastasis, indicating that HOTTIP may be a biomarker for lymph node metastasis in patients with pancreatic cancer and provide a basis for pancreatic cancer targeting therapy. This evidence concerns the gene HOTTIP and metastatic malignant neoplasm in the lymph nodes.